Enduring Material CME: Diabetes CME: Screening and diagnosis of microvascular complications: International Medical Press: August, 2008 - August 31, 2009

Screening and diagnosis of microvascular complications



CME Sponsor: 

International Medical Press


Location:
This is a web-based enduring material CME

Course Directors/Instructors:
Etie Moghissi, MD, FACP, FACE
Associate Clinical Professor of Medicine
University of California, Los Angeles
Los Angeles, CA

Harold Lebovitz, MD, FACE
Professor of Medicine
Division of Endocrinology and Metabolism/Diabetes
SUNY Health Science Center
Brooklyn, NY

Vivian Fonseca, MD, FRCP, FACE
Professor of Medicine
Tullis-Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Medical Center
New Orleans, LA

David D’Allesio, MD
Professor of Medicine
Director, Division of Endocrinology, Diabetes and Metabolism
University of Cincinnati School of Medicine
Chief, Endocrinology and Diabetes Clinic
VA Medical Center
Cincinnati, OH

Registration Fees: Free

Number of Credits:
1.25 AMA PRA Category 1 Credit(s)™

Link

Detailed Description:

Diabetic microvascular complications (DMC), including retinopathy, nephropathy, and peripheral neuropathy, represent a major cause of morbidity among patients with diabetes. The purpose of this activity is to increase understanding of timely and appropriate screening and diagnostic procedures so that the heavy personal, social, and economic burdens of these conditions may be mitigated.

Learning Objectives:

  • List the signs and symptoms of each of the 3 diabetic microvascular complications (DMC), including diabetic retinopathy, diabetic nephropathy, and diabetic peripheral neuropathy
  • Utilize the appropriate scales and diagnostic instruments available for screening patients with diabetes for diabetic peripheral neuropathy
  • Apply appropriate screening practices for diabetic retinopathy and macular edema in clinical practice
  • Determine the need for referring patients to a specialist, such as an ophthalmologist, based on results from diabetic retinopathy screening
  • Employ standard screening and diagnostic tests for identifying patients with early manifestations of diabetic nephropathy
  • Differentiate the sensitivity of various routine screening methods for diabetic nephropathy and determine the need for advanced screening











Comments

No Comments Found.

How would you rate the quality of this CME opportunity?
Rating: * Poor Excellent
Your Name:
Your Email:
Your Comment: *
Verification * img

Please copy the characters from the image above into the text field below. Doing this helps us prevent automated submissions.
 

This review is the subjective opinion of a CME Networks site member or user and not of CME Networks, LLC.

CMENetworks.com Comment Policy: CMEnetworks.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene or other material that would violate the law. Please note that CMEnetworks.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors or commentors. By submitting your comment, you hereby give CMEnetworks.com the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now know or hereafter devised, worldwide, in perpetuity.

medical vendor 

directory for CME
medical vendor directory for CME medical vendor 

directory for CME